Arkolith/Insider Trading/INFI/Form 4

Perkins Adelene Q

DirectorINFINITY PHARMACEUTICALS, INC. (INFI) · full profile →Form 4 · filed Sep 12, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$29K
Net Open-Market Flow
-$29K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2023Sell(S)410K$0.07$29K1.2M
Sep 9, 2023Option exercise(M)768K——1.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 9, 2023Option exercise(M)768K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-018762) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML